B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

The canonical retinoid cycle in rods (twilight vision)

REACTOME PATHWAY
Reactome: R-HSA-24539023 genes19 compounds

The The canonical retinoid cycle in rods (twilight vision) pathway (Reactome ID: R-HSA-2453902) involves 3 genes and is affected by 19 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

HSD17B1RBP4TTR

Compounds Affecting The canonical retinoid cycle in rods (twilight vision)

#CompoundTargets HitStudies
1Apigenin 5,7,4'-trihydroxy-flavone,300
2Masoprocol300
3Genistein300
4Kaempferols300
5Vitamin295
6Niflumic Acid300
7Thyroxine994
8Luteolin 5,7,3',4'-tetrahydroxy-flavone,150
9pterostilbene299
10piceatannol300
11Thyroxine300
12egcg300
13Resveratrol298
14Rosmarinic Acid300
15Dextrothyroxine134
16Gemfibrozil297
17Triiodothyronine300
18Estrone300
19Kaempferols300

About the The canonical retinoid cycle in rods (twilight vision) Pathway

The The canonical retinoid cycle in rods (twilight vision) pathway is catalogued in Reactome (ID: R-HSA-2453902) and involves 3 genes. In the BiohacksAI corpus, 19 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include HSD17B1, RBP4, TTR.